Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

There are no communication police but HHS does have some internal documents explaining principals and practice standards for scientific communications. From The Office of the Assistant Secretary for ...

A new global study found that COVID-19 vaccines saved more than 2.5 million lives worldwide between 2020 and 2024 — and nearly 9 out of 10 of those lives were people aged 60 and older.

A Stanford University-led investigation into the COVID-19 vaccination effort reports that it averted an estimated 2.533 ...

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

If drug developers are allowed to skip this step, it will mean that, in the near future, the first living body a new drug is ever tested in will be a human.